Mesirow Institutional Investment Management Inc. Purchases 77,603 Shares of Surgery Partners, Inc. (NASDAQ:SGRY)

Mesirow Institutional Investment Management Inc. lifted its stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 12.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 677,464 shares of the company's stock after acquiring an additional 77,603 shares during the period. Mesirow Institutional Investment Management Inc. owned 0.53% of Surgery Partners worth $14,342,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Principal Financial Group Inc. acquired a new stake in shares of Surgery Partners in the third quarter worth $1,469,000. Geode Capital Management LLC increased its stake in Surgery Partners by 2.4% during the 3rd quarter. Geode Capital Management LLC now owns 1,864,346 shares of the company's stock worth $60,117,000 after buying an additional 42,897 shares during the period. AlphaCentric Advisors LLC purchased a new stake in shares of Surgery Partners during the fourth quarter worth about $374,000. JPMorgan Chase & Co. boosted its stake in Surgery Partners by 3.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 189,436 shares of the company's stock valued at $6,107,000 after acquiring an additional 5,551 shares during the last quarter. Finally, Norges Bank bought a new position in shares of Surgery Partners during the fourth quarter worth about $15,796,000.

Insider Buying and Selling

In related news, insider Marissa Brittenham sold 3,156 shares of the firm's stock in a transaction on Monday, March 10th. The shares were sold at an average price of $24.09, for a total value of $76,028.04. Following the completion of the transaction, the insider now directly owns 63,408 shares of the company's stock, valued at approximately $1,527,498.72. This trade represents a 4.74 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO David T. Doherty sold 6,733 shares of the firm's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $24.02, for a total transaction of $161,726.66. Following the completion of the sale, the chief financial officer now owns 150,868 shares of the company's stock, valued at $3,623,849.36. This trade represents a 4.27 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 106,622 shares of company stock worth $2,717,860 over the last ninety days. Company insiders own 2.30% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have commented on SGRY shares. Macquarie reduced their target price on Surgery Partners from $34.00 to $33.00 and set an "outperform" rating on the stock in a report on Tuesday, March 11th. Benchmark reaffirmed a "buy" rating and set a $35.00 target price on shares of Surgery Partners in a report on Monday. Finally, Royal Bank of Canada reiterated an "outperform" rating and issued a $35.00 target price on shares of Surgery Partners in a research note on Tuesday, March 25th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $34.75.

Surgery Partners Price Performance

NASDAQ:SGRY traded down $0.42 during mid-day trading on Friday, hitting $21.43. The company's stock had a trading volume of 445,245 shares, compared to its average volume of 1,093,578. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99. The stock has a fifty day moving average of $23.16 and a 200-day moving average of $24.15. The company has a market capitalization of $2.73 billion, a price-to-earnings ratio of -44.66, a P/E/G ratio of 19.21 and a beta of 2.40. Surgery Partners, Inc. has a fifty-two week low of $19.50 and a fifty-two week high of $33.97.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last issued its quarterly earnings results on Monday, March 3rd. The company reported $0.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.01. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The business had revenue of $864.40 million for the quarter, compared to the consensus estimate of $828.09 million. As a group, equities analysts forecast that Surgery Partners, Inc. will post 0.67 EPS for the current fiscal year.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.